Wermke, M., Alt, J., Bozorgmehr, F., Fuchs, F., Rusquec, P. D., Gazzah, A., Dulloo, S., Kalinka, E., Chauhan, A., Mosikian, A., Kirner, S., Yang, D., Sayehli, C. (2025). DAREONTM-9, a phase Ib study of obrixtamig plus topotecan in patients (pts) with advanced small cell lung cancer (SCLC): Interim analysis results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8094